Nibla, Cherry Cris .

HRN: 25-90-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2024
AMPICILLIN 1GM (VIAL)
09/21/2024
09/28/2024
IV
2 GRAMS
Q6
PROM X 4 HRS; THINLY MSAF
Waiting Final Action 
09/21/2024
CEFUROXIME 500MG (TAB)
09/21/2024
09/28/2024
PO
500mg
BID
S/P NSVD With RMLE And Repair, PROM X 8hrs, Thinly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: